Diabeloop

Diabeloop Overview

  • Status
  • Private
  • Employees
  • 50
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $34.3M
Latest Deal Amount
  • Investors
  • 13

Diabeloop General Information

Description

Developer of an artificial pancreas system created to improve treatment for Type 1 diabetes patients. The company's artificial pancreas system, envisioned in the joint lab will automatically deliver the appropriate dose of insulin to patients, it includes a sensor that measures patients' glucose levels, a pump that delivers insulin and a smartphone with an embedded algorithm and patient interface that links the sensor and the pump, it also includes telemedicine capabilities for monitoring patients and linking them with health-care providers and dedicated nurses, enabing patients to improve everyday life of diabetes patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Primary Office
  • 155-157 Cours Berriat
  • 38000 Grenoble
  • France

Diabeloop Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Diabeloop Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 02-Dec-2019 $34.3M 000.00 0000 Completed Generating Revenue
4. Early Stage VC (Series A) 21-Sep-2017 000.00 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Grant 01-Jan-2011 Completed Startup

Diabeloop Cap Table

To view Diabeloop‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P Shares 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
P Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000

Diabeloop Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Boston Scientific Corporation Marlborough, MA 00000 000000&0
000000 Venture Capital-Backed Mountain View, CA 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Milpitas, CA 00 00000 00000000000 00000

Diabeloop Executive Team (3)

Name Title Board Seat Contact Info
Erik Huneker Co-Founder & Co-Chief Executive Officer
Marc Julien Co-Chief Executive Officer
Guillaume Charpentier Co-Founder, Chairman & President

Diabeloop Board Members (2)

Name Representing Role Since
Guillaume Charpentier Diabeloop Co-Founder, Chairman & President 000 0000
Meinhard Schmidt Self Board Member 000 0000

Diabeloop Investors (13)

To view Diabeloop‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AGIR à dom Other Minority 000 0000 000000 0
Cemag Invest Family Office Minority 000 0000 000000 0
Odyssee Venture PE/Buyout Minority 000 0000 000000 0
Reliance Anil Dhirubhai Ambani Group Corporation Minority 000 0000 000000 0
Air Liquide Venture Capital Corporate Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial